SNDX
Syndax Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +8.3% ·
flujo de acciones -10.7% ·
nuevas posiciones netas +7.7%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 93 | -1 | 57.50M | $1.26B | +8 | −9 |
| Q1 2026 | 97 | +6 | 52.14M | $1.22B | +10 | −4 |
| Q4 2025 | 91 | -3 | 57.71M | $1.21B | — | −3 |
| Q3 2025 | 20 | +1 | 39.69M | $610.59M | +1 | — |
| Q2 2025 | 16 | +1 | 29.55M | $276.77M | +1 | — |
| Q1 2025 | 12 | -1 | 16.71M | $205.25M | — | −1 |
| Q4 2024 | 13 | +1 | 16.01M | $211.65M | +1 | — |
| Q3 2024 | 11 | -1 | 14.02M | $269.82M | — | −1 |
| Q2 2024 | 12 | — | 17.35M | $356.12M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.23M | -15.1% | $55.98M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (pasivo) | 3.92M | — | $51.79M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasivo) | 1.97M | -0.2% | $26.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasivo) | 1.97M | -0.2% | $26.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.92M | -31.1% | $25.33M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 1.09M | +3103.4% | $14.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.09M | +3103.4% | $14.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 680.97K | Nuevo | $9.00M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 669.82K | -24.4% | $8.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 621.84K | -23.9% | $8.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 586.81K | -47.6% | $7.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 184.12K | -47.8% | $2.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 184.12K | -47.8% | $2.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 65.21K | +156.6% | $862,116 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 57.02K | +16.5% | $754,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Marshall Wace ✦ | 12.62K | -98.7% | $166,891 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 12.62K | -98.7% | $166,891 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Renaissance Technologies | $9.00M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 244 tenedores, 99.11M acciones, $2.29B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.